top of page

Thyroid-Stimulating Hormone (INFANT)

The TSH Infant clinical Study is a sample collection and hormone research study for infants ages 1 month to 23 months. This study is designed to support clinical research related to thyroid hormone testing and infant health.

Thyroid hormones play an important role in a baby’s growth, brain development, metabolism, and overall early development. In newborn and infant health, TSH and thyroid hormone levels may help researchers better understand thyroid function and improve future testing methods.

Participation may involve a simple sample collection process by trained clinical research staff. Our team will explain the study details, review basic eligibility, and guide parents or guardians through each step before participation.

This is a research study and not a replacement for medical care. Parents should always speak with their child’s healthcare provider for any medical concerns.

ChatGPT Image Jul 1, 2026, 06_22_26 PM.png

Who May Be Eligible?

Your infant may be able to participate in the TSH-3 Infant Study if they meet basic study requirements. Our clinical research team will review eligibility and explain the process clearly before any participation begins.

  • Infant Age Requirement
    Infants between 1 month and 23 months of age may be considered for this study.

  • Parent or Guardian Consent
    A parent or legal guardian must be available to provide permission and complete the study-related forms.

  • Basic Health Review
    Our team may ask a few health-related questions to help determine whether the study is suitable for your infant.

Contact Us

Address

7080 Southwest Fwy, Houston, TX 77074, United States

Contact

(713) 484-6947

bottom of page